THYROID CANCER, PAPILLARY
Clinical trials for THYROID CANCER, PAPILLARY explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER, PAPILLARY trials appear
Sign up with your email to follow new studies for THYROID CANCER, PAPILLARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a melanoma drug combo tame rare BRAF cancers?
Disease control Recruiting nowThis trial is testing two drugs, vemurafenib and cobimetinib, already approved for melanoma, in adults with other rare cancers that have a specific genetic change called BRAF V600 mutation. The goal is to see if the combination can shrink tumors or stop them from growing. About 3…
Matched conditions: THYROID CANCER, PAPILLARY
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New scoring system could rate robot thyroid surgeons
Knowledge-focused Recruiting nowThis study aims to create and test a scoring system called RTAS to evaluate how well surgeons perform robotic thyroidectomy, a surgery to remove all or part of the thyroid gland. Researchers will observe 200 participants with thyroid cancer or benign nodules who are having this s…
Matched conditions: THYROID CANCER, PAPILLARY
Sponsor: Shanghai 6th People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC